ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 3112

DOCK8 Associates with STAT5 and Promotes Regulatory T Cell Function

Erin Janssen1, Mira Tohme1, Sumana Ullas2 and Raif Geha2, 1Immunology, Boston Children's Hospital, Boston, MA, 2Boston Children's Hospital, Boston, MA

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: Auto-immunity, autoantibodies and signal transduction, T-Regulatory Cells

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: T Cell Biology and Targets in Autoimmune Disease - Oral Session

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: DOCK8 deficiency leads to autosomal recessive Hyper-IgE syndrome (AR-HIES). DOCK8 deficient patients develop recurrent sinopulmonary infections, chronic mucocutaneous viral infections, hyper-IgE, eosinophilia, food allergies, and severe dermatitis [1, 2]. We previously reported that the number and in vitro suppressive function of circulating regulatory T (Treg) cells are significantly reduced in DOCK8 deficient patients [3]. Paradoxically, they seldom develop autoimmunity, we propose that this is due to their impaired T effector (Teff) cell function.

Methods: We generated and analyzed Dock8-/- mice and mice with a selective DOCK8 deficiency in their Treg cells. Treg cell markers and in vitro suppressive function were investigated using flow cytometry. STAT5 phosphorylation was measured by flow cytometry and confocal microscopy. Using co-immunoprecipitation experiments, we examined the association between DOCK8 and STAT5.

Results: We determined that Dock8-/- mice have decreased Treg numbers and impaired in vitro function of Treg cells, but do not develop autoimmunity. In contrast, mice with selective DOCK8 deficiency in their Treg cells spontaneously develop lymphoproliferation, autoantibodies, and severe gastrointestinal inflammation, despite normal percentages of Treg cells. We found that DOCK8 associates with STAT5 and plays crucial role in IL-2 driven STAT5 phosphorylation and nuclear translocation in Treg cells. These findings indicate that DOCK8 expression in Treg cells plays a critical role in self-tolerance by enhancing IL-2 driven STAT5 signaling, which is essential for Treg cell function, and suggest that deficient Teff cell function might protect DOCK8 deficient patients from autoimmunity.

Conclusion: These findings suggest that DOCK8 expression in Treg cells plays a critical role in self-tolerance by enhancing IL-2 driven STAT5 signaling. Furthermore, our data support the hypothesis that deficient Teff cell function may protect DOCK8 deficient patients from autoimmunity. References:

1. Engelhardt, K.R., et al., Large deletions and point mutations involving the dedicator of cytokinesis 8 (DOCK8) in the autosomal-recessive form of hyper-IgE syndrome.J Allergy Clin Immunol, 2009. 124(6): p. 1289-302 e4.

2. Zhang, Q., et al., Combined immunodeficiency associated with DOCK8 mutations.The New England journal of medicine, 2009. 361(21): p. 2046-55.

3. Janssen, E., et al., Dedicator of cytokinesis 8-deficient patients have a breakdown in peripheral B-cell tolerance and defective regulatory T cells. The Journal of allergy and clinical immunology, 2014.


Disclosure: E. Janssen, None; M. Tohme, None; S. Ullas, None; R. Geha, None.

To cite this abstract in AMA style:

Janssen E, Tohme M, Ullas S, Geha R. DOCK8 Associates with STAT5 and Promotes Regulatory T Cell Function [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/dock8-associates-with-stat5-and-promotes-regulatory-t-cell-function/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/dock8-associates-with-stat5-and-promotes-regulatory-t-cell-function/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology